Sinopharm Group Co. Ltd.
HKSE:1099.HK
Sector
Location
Market Cap
USD 7.68 B
Share Price
USD 2.46
Avg Daily Volume
6,762,279
Change (1 day)
-0.21%
Change (1 year)
4.54%
Change (YTD)
-10.23%
Sinopharm Group Co. Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 1.58 B
Sinopharm Group Co. Ltd. Operating Cash Flow is USD 1.58 B for the year ending December 31, 2024, a -34.62% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Sinopharm Group Co. Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 2.42 B, a -20.38% change year over year.
-
Sinopharm Group Co. Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 3.04 B, a 107.38% change year over year.
-
Sinopharm Group Co. Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 1.46 B, a -14.28% change year over year.
-
Sinopharm Group Co. Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 1.71 B, a -36.62% change year over year.
StockViz
Competitors
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
McKesson Corporation
USD 711.82
MCK
+1.63
0.23%
Elevance Health Inc.
USD 289.10
ELV
+8.67
3.09%
Cencora, Inc.
USD 290.36
COR
-0.09
-0.03%
BeOne Medicines Ltd.
USD 291.47
ONC
-4.99
-1.68%
JD Health International Inc.
USD 6.13
6618.HK
-0.03
-0.52%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.40
2196.HK
+0.04
1.73%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.62
2607.HK
-0.01
-0.47%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.72
002653.SZ
+0.01
0.22%
Hikma Pharmaceuticals PLC
USD 26.93
HIK.L
-0.46
-1.68%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.32
0874.HK
-0.05
-1.93%
Galenica AG
USD 110.28
GALE.SW
-0.68
-0.61%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.06
600079.SS
-0.04
-1.32%
Option Care Health, Inc.
USD 29.69
OPCH
+0.22
0.75%
China Resources Pharmaceutical Group Limited
USD 0.71
3320.HK
-0.01
-1.24%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
McKesson Corporation
USD 711.82
MCK
+1.63
0.23%
Elevance Health Inc.
USD 289.10
ELV
+8.67
3.09%
Cencora, Inc.
USD 290.36
COR
-0.09
-0.03%
BeOne Medicines Ltd.
USD 291.47
ONC
-4.99
-1.68%
JD Health International Inc.
USD 6.13
6618.HK
-0.03
-0.52%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.40
2196.HK
+0.04
1.73%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.62
2607.HK
-0.01
-0.47%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.72
002653.SZ
+0.01
0.22%
Hikma Pharmaceuticals PLC
USD 26.93
HIK.L
-0.46
-1.68%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.32
0874.HK
-0.05
-1.93%
Galenica AG
USD 110.28
GALE.SW
-0.68
-0.61%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.06
600079.SS
-0.04
-1.32%
Option Care Health, Inc.
USD 29.69
OPCH
+0.22
0.75%
China Resources Pharmaceutical Group Limited
USD 0.71
3320.HK
-0.01
-1.24%